Phase II BGG492 Capsule Extension for Partial Epilepsy
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This long-term extension study will assess the safety, tolerability and efficacy of BGG492 as
adjunctive treatment in patients with partial onset seizures.